- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 7/64 - Cyclic peptides containing only normal peptide links
Patent holdings for IPC class C07K 7/64
Total number of patents in this class: 1639
10-year publication summary
|
126
|
134
|
137
|
121
|
133
|
129
|
137
|
117
|
134
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Polyphor AG | 99 |
58 |
| The University of British Columbia | 1468 |
30 |
| Entrada Therapeutics, Inc. | 64 |
30 |
| Allergan, Inc. | 2438 |
26 |
| Chugai Seiyaku Kabushiki Kaisha | 1318 |
26 |
| Bicyclerd Limited | 138 |
26 |
| The Regents of the University of California | 19517 |
24 |
| Ohio State Innovation Foundation | 1978 |
24 |
| Protagonist Therapeutics, Inc. | 142 |
23 |
| Centre National de La Recherche Scientifique | 10102 |
16 |
| Universitat Zurich | 637 |
16 |
| The University of Tokyo | 4060 |
16 |
| Heidelberg Pharma Research GmbH | 74 |
16 |
| Technische Universitat Munchen | 677 |
15 |
| University of Southern California | 2077 |
14 |
| Polyphor Ltd. | 21 |
14 |
| Novartis AG | 11254 |
12 |
| Bristol-myers Squibb Company | 4863 |
12 |
| University of South Florida | 1827 |
12 |
| Apellis Pharmaceuticals, Inc. | 117 |
12 |
| Other owners | 1217 |